Literature DB >> 4985432

Spectra of susceptibility of Neisseria meningitidis to antimicrobial agents in vitro.

L F Devine, C R Hagerman.   

Abstract

The minimal inhibitory concentrations of 49 antimicrobial agents for 37 to 40 meningococcal strains freshly isolated from the nasopharynx of healthy carriers were determined. Coumermycin A(1) and rifampin were the most effective agents tested. The geometric mean values of the minimal inhibitory concentrations for coumermycin A(1) and rifampin were 0.0001 and 0.02 mug/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4985432      PMCID: PMC376678          DOI: 10.1128/am.19.2.329-334.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  8 in total

1.  IN VIVO AND IN VITRO RESISTANCE TO SULFADIAZINE IN STRAINS OF NEISSERIA MENINGITIDIS.

Authors:  J W MILLAR; E E SIESS; H A FELDMAN; C SILVERMAN; P FRANK
Journal:  JAMA       Date:  1963-10-12       Impact factor: 56.272

2.  CHANGING SUSCEPTIBILITY OF MENINGOCOCCI TO ANTIMICROBIAL AGENTS.

Authors:  T C EICKHOFF; M FINLAND
Journal:  N Engl J Med       Date:  1965-02-25       Impact factor: 91.245

3.  An experiment in the prevention of meningococcal meningitis in Nigeria.

Authors:  R L VOLLUM; P W GRIFFITHS
Journal:  J Clin Pathol       Date:  1962-01       Impact factor: 3.411

4.  In vitro susceptibility of meningococci to eleven antibiotics and sulfadiazine.

Authors:  B D LOVE; M FINLAND
Journal:  Am J Med Sci       Date:  1954-11       Impact factor: 2.378

5.  Sulfonamide-resistant meningococcal disease.

Authors:  R C Singer
Journal:  Med Clin North Am       Date:  1967-05       Impact factor: 5.456

6.  Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci.

Authors:  J M Dowd; D Blink; C H Miller; P F Frank; W E Pierce
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

7.  Proposed model for screening antimicrobial agents for potential use in eliminating meningococci from the nasopharynx of healthy carriers.

Authors:  L F Devine; R C Knowles; W E Pierce; R O Peckinpaugh; C R Hagerman; R I Lytle
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

8.  Sulfadiazine-resistant group A Neisseria meningitidis.

Authors:  C E Alexander; W R Sanborn; G Cherriere; W H Crocker; P E Ewald; C R Kay
Journal:  Science       Date:  1968-09-06       Impact factor: 47.728

  8 in total
  7 in total

1.  Susceptibility of Neisseria meningitidis strains from the civilian population to sulfadiazine, penicillin, and rifampin.

Authors:  G L Wiggins; J V McLaughlin; S T Bickham; W L Jones; A Balows
Journal:  Appl Microbiol       Date:  1970-12

2.  Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrations.

Authors:  J A Sáez-Nieto; D Fontanals; J Garcia de Jalon; V Martinez de Artola; P Peña; M A Morera; R Verdaguer; I Sanfeliu; C Belio-Blasco; J L Perez-Saenz
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

3.  Neisseria meningitidis serogroup B peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  G Conrads; G Haase; N Schnitzler; I Ehrhard; H Schmitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

4.  Characteristics of pathogenic Neisseria spp. isolated from homosexual men.

Authors:  W M Janda; J A Morello; S A Lerner; M Bohnhoff
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

5.  Entry of four tetracyclines into saliva and tears.

Authors:  P D Hoeprich; D M Warshauer
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

6.  Comparison of susceptibility of Neisseria meningitidis to sodium sulphadiazine and sodium fusidate in vitro.

Authors:  R S Miles; A Moyes
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

7.  Pharmacodynamics of antimicrobials against Mycoplasma mycoides mycoides small colony, the causative agent of contagious bovine pleuropneumonia.

Authors:  John D Mitchell; Quintin A McKellar; Declan J McKeever
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.